Skip to main content

Table 1 Year of regulatory approval in Italy of antiretroviral drugs, 1987-2008

From: Determinants of access to experimental antiretroviral drugs in an Italian cohort of patients with HIV: a multilevel analysis

Year NRTI NNRTI PI EI II
1987 Zidovudine (AZT)     
1992 Didanosine     
1995 Zalcitabine     
1996 Stavudine
Lamivudine (3TC)
  Indinavir
Ritonavir
Saquinavir HG
  
1998 AZT/3TC Co-formulation Nevirapine Nelfinavir   
1999 Abacavir (ABC) Efavirenz Saquinavir SG   
2001 ABC/AZT/3TC Co-formulation   Amprenavir
Lopinavir/Ritonavir
  
2002 Tenofovir (TDF)     
2004    Atazanavir Enfuvirtide  
2005 Emtricitabine (FTC)
TDF/FTC Co-formulation
ABC/3TC Co-formulation
  Fosamprenavir
Tripanavir
  
2007    Darunavira   
2008     Maraviroca Raltegravira
Not approved   Delavirdine
Atevirdine
DP 083
   
  1. NRTI = Nucleoside Reverse Transcriptase Inhibitor; NNRTI = Non-nucleoside Reverse Transcriptase Inhibitor; PI = protease inhibitors; EI = Entry
  2. and Fusion Inhibitors; II = Integrase Inhibitor
  3. a Not used in the IcoNa cohort prior to regulatory approval